Treatment of severe rash caused by crizotinib with both traditional Chinese medicine and Western medicine: Two case reports and literature review

RATIONALE: Lung adenocarcinoma is the most common pathologic pattern of lung cancer. During the past decades, a number of targeted agents have been explored to treat advanced lung adenocarcinoma. Recently, Crizotinib, the antagonist of anaplastic lymphoma kinase (ALK), has been widely used in ALK-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Shu-Yue, Shen, Wen, Peng, Yan-Mei, Cui, Hui-Juan, Duan, Hua, Qiu, Yu-Qin, Li, Qiang, Zhang, Jing-Yi, Sun, Chen-Yao, Zhang, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283193/
https://www.ncbi.nlm.nih.gov/pubmed/30508887
http://dx.doi.org/10.1097/MD.0000000000013088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283193/
https://www.ncbi.nlm.nih.gov/pubmed/30508887
http://dx.doi.org/10.1097/MD.0000000000013088

Ejemplares similares